Plasma homocysteine and calcific aortic valve disease
- PMID: 15201256
- PMCID: PMC1768317
- DOI: 10.1136/hrt.2003.022889
Plasma homocysteine and calcific aortic valve disease
Similar articles
-
Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.J Am Coll Cardiol. 2007 Nov 13;50(20):1992-8. doi: 10.1016/j.jacc.2007.07.064. Epub 2007 Oct 29. J Am Coll Cardiol. 2007. PMID: 17996566
-
The relation between homocysteine and calcific aortic valve stenosis.Cardiology. 2005;103(4):207-11. doi: 10.1159/000085199. Epub 2005 Apr 15. Cardiology. 2005. PMID: 15838165
-
Is it time for a new paradigm in calcific aortic valve disease?JACC Cardiovasc Imaging. 2009 Aug;2(8):928-30. doi: 10.1016/j.jcmg.2009.02.016. JACC Cardiovasc Imaging. 2009. PMID: 19679279 No abstract available.
-
Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.Circulation. 2005 Jun 21;111(24):3316-26. doi: 10.1161/CIRCULATIONAHA.104.486738. Circulation. 2005. PMID: 15967862 Review. No abstract available.
-
[Pathogenesis of calcific aortic valve stenosis].Herz. 2006 Oct;31(7):620-8. doi: 10.1007/s00059-006-2888-5. Herz. 2006. PMID: 17072774 Review. German.
Cited by
-
Dephosphorylation of circulating human osteopontin correlates with severe valvular calcification in patients with calcific aortic valve disease.Biomarkers. 2012 Mar;17(2):111-8. doi: 10.3109/1354750X.2011.642407. Epub 2011 Dec 23. Biomarkers. 2012. PMID: 22191734 Free PMC article.
-
Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition.Nutrients. 2023 Dec 30;16(1):135. doi: 10.3390/nu16010135. Nutrients. 2023. PMID: 38201964 Free PMC article. Review.
-
Metabolomics in Severe Aortic Stenosis Reveals Intermediates of Nitric Oxide Synthesis as Most Distinctive Markers.Int J Mol Sci. 2021 Mar 30;22(7):3569. doi: 10.3390/ijms22073569. Int J Mol Sci. 2021. PMID: 33808189 Free PMC article.
-
Association between homocysteine levels and calcific aortic valve disease: a systematic review and meta-analysis.Oncotarget. 2018 Jan 3;9(9):8665-8674. doi: 10.18632/oncotarget.23938. eCollection 2018 Feb 2. Oncotarget. 2018. PMID: 29492225 Free PMC article.
-
Insights into the use of biomarkers in calcific aortic valve disease.J Heart Valve Dis. 2010 Jul;19(4):441-52. J Heart Valve Dis. 2010. PMID: 20845891 Free PMC article. Review.
References
-
- Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844–53. - PubMed
-
- Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol 1997;29:630–4. - PubMed
-
- Clarke R , Daly L, Robinson K, et al. Hyperhomocystinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149–55. - PubMed
-
- Chan KL, Ghani M, Woodend K, et al. Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. Am J Cardiol 2001;88:690–3. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical